2026 Derek O'hagan: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	103	653	602	59	55	314	31460
Medicine	103	7450	6999	727	693	317	31461

Derek O'hagan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Derek O'hagan sits on this spectrum.

62 publications 807+

This scientist: 314 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Derek O'hagan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Derek O'hagan sits on this spectrum.

40 D-Index 157+

This scientist: 103 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

2023 - Research.com Medicine in Switzerland Leader Award

Overview

Derek O'hagan is affiliated with GlaxoSmithKline in the United Kingdom and has a research focus primarily in the fields of Medicine and Immunology and Microbiology. Their work extensively covers subfields such as Immunology, Infectious Diseases, and Molecular Biology.

The scientist's main topics of research include Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Immune Response and Inflammation, Animal Virus Infections Studies, RNA Interference and Gene Delivery, Viral Infections and Immunology Research, and vaccines and immunoinformatics approaches.

O'hagan has published several recent papers in notable scientific journals, including:

Emerging concepts in the science of vaccine adjuvants, 2021, Nature Reviews Drug Discovery
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity, 2021, Nature
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines, 2021, Cell
Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection, 2020, Journal of Controlled Release
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines, 2021, Molecular Pharmaceutics

Frequent coauthors collaborating with O'hagan include Bali Pulendran, Prabhu S. Arunachalam, Harry Kleanthous, Robbert van der Most, and François Villinger.

The scientist's publications appear regularly in the following venues:

npj Vaccines
Journal of Controlled Release
bioRxiv (Cold Spring Harbor Laboratory)
Pharmaceutics
Vaccines

Best Publications

Emerging concepts in the science of vaccine adjuvants.

Bali Pulendran;Prabhu S. Arunachalam;Derek T. O’Hagan

1240
Citations
Nonviral delivery of self-amplifying RNA vaccines

Andrew J. Geall;Ayush Verma;Gillis R. Otten;Christine A. Shaw

712
Citations
Advances in vaccine adjuvants.

Manmohan Singh;Derek O'Hagan

698
Citations
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

Fiona A Sharp;Darren Thomas Ruane;Benjamin Claass;Emma Creagh

659
Citations
Cationic microparticles: A potent delivery system for DNA vaccines

Manmohan Singh;Maylene Briones;Gary Ott;Derek O'Hagan

638
Citations
Molecular and cellular signatures of human vaccine adjuvants

F. Mosca;E. Tritto;A. Muzzi;E. Monaci

604
Citations
Recent advances in the discovery and delivery of vaccine adjuvants.

Derek T. O'Hagan;Nicholas M. Valiante

579
Citations
The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells

Anja Seubert;Elisabetta Monaci;Mariagrazia Pizza;Derek T. O’Hagan

530
Citations
The mechanism of action of MF59 - an innately attractive adjuvant formulation.

D.T. O’Hagan;G.S. Ott;E. De Gregorio;A. Seubert

517
Citations
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.

Samuele Calabro;Marco Tortoli;Barbara C. Baudner;Alessandra Pacitto

498
Citations
Recent developments in adjuvants for vaccines against infectious diseases.

Derek T. O'Hagan;Mary Lee MacKichan;Manmohan Singh

464
Citations
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.

Harm HogenEsch;Derek T. O’Hagan;Christopher B. Fox

377
Citations
Biodegradable microparticles as controlled release antigen delivery systems.

D T O'Hagan;D Rahman;J P McGee;H Jeffery

376
Citations
The history of MF59® adjuvant: a phoenix that arose from the ashes

Derek T O'Hagan;Gary S Ott;Gary Van Nest;Rino Rappuoli

376
Citations
Recent advances in vaccine adjuvants.

Manmohan Singh;Derek T. O'Hagan

349
Citations
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Luis A Brito;Michelle Chan;Christine A Shaw;Armin Hekele

338
Citations
The path to a successful vaccine adjuvant--'the long and winding road'.

Derek T. O’Hagan;Ennio De Gregorio

330
Citations
Nanoparticles and microparticles as vaccine-delivery systems.

Manmohan Singh;Aravind Chakrapani;Derek O'Hagan

329
Citations
Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.

Derek T O'Hagan;Manmohan Singh;Rajesh K Gupta

327
Citations
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.

Prabhu S. Arunachalam;Alexandra C. Walls;Nadia Golden;Caroline Atyeo

324
Citations
MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection

Derek T O'Hagan

313
Citations

Frequent Co-Authors

John J. Donnelly Novartis (United States)

Susan W. Barnett Bill & Melinda Gates Foundation

Jeffrey B. Ulmer Novartis (Switzerland)

Rino Rappuoli Imperial College London

Nicholas M. Valiante Novartis (Switzerland)

Ed C. Lavelle Trinity College Dublin

Ennio De Gregorio Novartis (Switzerland)

Andreas Wack The Francis Crick Institute

Wayne C. Koff International AIDS Vaccine Initiative

Philip R. Dormitzer Pfizer (United States)

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing a career in immunology opens doors to various related healthcare fields, many of which offer flexible online degree options. For those interested in nursing, understanding which path suits your goals is crucial. Exploring the fastest and easiest LPN programs can be a great starting point for entering the nursing profession quickly while gaining essential clinical experience.

If you're aiming for advanced practice roles, knowing which nurse practitioner program is easiest to complete online could help streamline your education journey. Specializing further, particularly in psychiatric mental health, is highly relevant for immunology professionals interested in the mind-body connection.

Online options abound, including top online PMHNP programs that offer excellent clinical placement opportunities, essential for hands-on training. Additionally, affordability matters; many students seek out affordable PMHNP programs to balance quality education with financial sustainability.

These options complement an immunology background, enabling graduates to diversify their skill set and career options within the evolving healthcare landscape.